Phase I trial evaluating safety and efficacy of intratumorally administered inflammatory allogeneic dendritic cells (ilixadencel) in advanced gastrointestinal stromal tumors
In: Cancer immunology, immunotherapy : CII, Jg. 69 (2020), Heft 11, S. 2393-2401
Online
academicJournal
Zugriff:
Titel: |
Phase I trial evaluating safety and efficacy of intratumorally administered inflammatory allogeneic dendritic cells (ilixadencel) in advanced gastrointestinal stromal tumors
|
---|---|
Autor/in / Beteiligte Person: | Frobom, R ; Berglund, E ; Berglund, D ; Nilsson, IL ; Ahlen, J ; von Sivers, K ; Linder-Stragliotto, C ; Suenaert, P ; Karlsson-Parra, A ; Branstrom, R |
Link: | |
Zeitschrift: | Cancer immunology, immunotherapy : CII, Jg. 69 (2020), Heft 11, S. 2393-2401 |
Veröffentlichung: | 2020 |
Medientyp: | academicJournal |
ISSN: | 1432-0851 (print) |
DOI: | 10.1007/s00262-020-02625-5 |
Schlagwort: |
|
Sonstiges: |
|